SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 02, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other most profitable biotech stocks to buy right now.

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Great Place to Work® and Fortune magazine recognized the company as one of the Fortune 100 Best ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Hillel International’s CEO expressed concern over the Trump administration’s plans to deport pro-Palestinian students and freeze federal funding to schools over campus antisemitism. The ...

Kingspan looks to have stuck to its 2022 promise to expand in Ukraine, after it broke ground on a new plant at Lviv in the west of the country. The Cavan-based firm has been granted permission to ...

NEW YORK - The 36 new special patrol officers announced last month by Columbia University were appointed by the New York Police Department and will be subject to the orders of the police ...

The school is the latest in the Ivy League to face penalties amid what the White House says is a bid to fight antisemitism. The Trump administration plans to freeze more than $500 million in ...

WASHINGTON, D.C. — US manufacturing activity contracted again in March, snapping a two-month expansion as firms contended with uncertainty over President Donald Trump's tariff plans, according to ...